1. Homegrown. Csl owns all of it. No royalties elsewhere
2. orphan designation regulatory fast track and exclusivity
3. Many more potential uses for this treatment as GS put it: a pipeline in a product.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$269.55 |
Change
-1.045(0.39%) |
Mkt cap ! $130.0B | |||
| Open | High | Low | Value | Volume |
| $269.50 | $272.00 | $268.56 | $32.98M | 122.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 46 | $269.54 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $269.57 | 17 | 4 |
View Market Depth
| Last trade - 12.18pm 29/07/2025 (20 minute delay) ? |
| CSL (ASX) Chart |